Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity
- 11 August 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 37 (6) , 2208-2223
Abstract
Post-stroke cognitive impairment is a major cause of long-term neurological disability. The prevalence of post-stroke cognitive deficits varies between 20% and 80% depending on brain region, country, and diagnostic criteria. The biochemical mechanisms underlying post-stroke cognitive impairment are not known in detail. Cyclin-dependent kinase 5 is involved in neurodegeneration, and its dysregulation contributes to cognitive disorders and dementia. Here, we administered cyclin-dependent kinase 5-targeting gene therapy to the right hippocampus of ischemic rats after transient right middle cerebral artery occlusion. Cyclin-dependent kinase 5 RNA interference prevented the impairment of reversal learning four months after ischemia as well as neuronal loss, tauopathy, and microglial hyperreactivity. Additionally, cyclin-dependent kinase 5 silencing increased the expression of brain-derived neurotrophic factor in the hippocampus. Furthermore, deficits in hippocampal long-term potentiation produced by excitotoxic stimulation were rescued by pharmacological blockade of cyclin-dependent kinase 5. This recovery was blocked by inhibition of the TRKB receptor. In summary, these findings demonstrate the beneficial impact of cyclin-dependent kinase 5 reduction in preventing long-term post-ischemic neurodegeneration and cognitive impairment as well as the role of brain-derived neurotrophic factor/TRKB in the maintenance of normal synaptic plasticity.Keywords
This publication has 40 references indexed in Scilit:
- CDK5 knockdown in astrocytes provide neuroprotection as a trophic source via Rac1Molecular and Cellular Neuroscience, 2015
- Phosphorylation of Synaptic GTPase-activating Protein (synGAP) by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and Cyclin-dependent Kinase 5 (CDK5) Alters the Ratio of Its GAP Activity toward Ras and Rap GTPasesJournal of Biological Chemistry, 2015
- Active Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Regulates NMDA Receptor Mediated Postischemic Long-Term Potentiation (i-LTP) by Promoting the Interaction between CaMKII and NMDA Receptors in IschemiaNeural Plasticity, 2014
- R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and SeizuresJournal of Neuroscience, 2012
- Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke ModelsPLOS ONE, 2010
- The Science of Stroke: Mechanisms in Search of TreatmentsNeuron, 2010
- Transient cerebral ischemia induces site-specific hyperphosphorylation of tau proteinBrain Research, 2004
- Mortality in patients with dementia after ischemic strokeNeurology, 2002
- Activation of p42 Mitogen-activated Protein Kinase in Hippocampal Long Term PotentiationJournal of Biological Chemistry, 1996
- Developments of a water-maze procedure for studying spatial learning in the ratJournal of Neuroscience Methods, 1984